Cargando…

2B4 Acts As a Non–Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells

Natural killer (NK) cells are critical in the immune response to tumor cells, virally infected cells, and bone marrow allografts. 2B4 (CD244) is expressed on all NK cells and the ligand for 2B4, CD48, is expressed on hematopoietic cells. Cross-linking 2B4 on NK cells with anti-2B4 monoclonal antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyung-Mi, McNerney, Megan E., Stepp, Susan E., Mathew, Porunelloor A., Schatzle, John D., Bennett, Michael, Kumar, Vinay
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211902/ https://www.ncbi.nlm.nih.gov/pubmed/15123744 http://dx.doi.org/10.1084/jem.20031989

Ejemplares similares

The haploinsufficient tumor suppressor, CUX1, acts as an analog transcriptional regulator that controls target genes through distal enhancers that loop to target promoters
por: Arthur, Robert K., et al.
Publicado: (2017)

Acquisition of External Major Histocompatibility Complex Class I Molecules by Natural Killer Cells Expressing Inhibitory Ly49 Receptors
por: Sjöström, Anna, et al.
Publicado: (2001)

Recognition of major histocompatibility complex class I antigens by natural killer cells
Publicado: (1994)

Human natural killer cells in major histocompatibility complex class I deficiency
por: Patil, Neha D., et al.
Publicado: (2021)

Lectin-like transcript 1 as a natural killer cell-mediated immunotherapeutic target for triple negative breast cancer and prostate cancer
por: Sun, Yuanhong, et al.
Publicado: (2019)

2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48
por: Brown, Marion H., et al.
Publicado: (1998)

The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity
por: Rajagopalan, Sumati, et al.
Publicado: (1997)

The D0 Domain of KIR3D Acts as a Major Histocompatibility Complex Class I Binding Enhancer
por: Khakoo, Salim I., et al.
Publicado: (2002)

Natural Killer Cell Tolerance in Mice with Mosaic Expression of Major Histocompatibility Complex Class I Transgene
por: Johansson, Maria H., et al.
Publicado: (1997)

A natural killer cell receptor specific for a major histocompatibility complex class I molecule
Publicado: (1994)

Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules
por: Johansson, Sofia, et al.
Publicado: (2005)

Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D
por: Sasaki, Michihito, et al.
Publicado: (2011)

Beginning Bazel: Building and Testing for Java, Go, and More
por: McNerney, PJ
Publicado: (2019)

Diagnostics for Developing Countries
por: McNerney, Ruth
Publicado: (2015)

Selection and Adaptation of Cells Expressing Major Histocompatibility Complex Class I–specific Receptors of the Natural Killer Complex
por: Bendelac, Albert
Publicado: (1997)

The Major Histocompatibility Complex in Transplantation
por: Ayala García, Marco Antonio, et al.
Publicado: (2012)

An ontology for major histocompatibility restriction
por: Vita, Randi, et al.
Publicado: (2016)

Major Histocompatibility Complex in Osteichthyes
por: Stosik, Michał, et al.
Publicado: (2020)

Congenital Atresia of the Aortic Orifice
por: McNerney, John C.
Publicado: (1937)

Low-Affinity Major Histocompatibility Complex–Binding Peptides in Type 1 Diabetes
por: James, Eddie A., et al.
Publicado: (2008)

Extracellular processing of peptide antigens that bind class I major histocompatibility molecules
Publicado: (1992)

An insulin peptide that binds an alternative site in class II major histocompatibility complex
Publicado: (1996)

The contribution of major histocompatibility complex contacts to the affinity and kinetics of T cell receptor binding
por: Zhang, Hao, et al.
Publicado: (2016)

USMPep: universal sequence models for major histocompatibility complex binding affinity prediction
por: Vielhaben, Johanna, et al.
Publicado: (2020)

Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions
por: Paul, Sinu, et al.
Publicado: (2020)

Long-read assembly of major histocompatibility complex and killer cell immunoglobulin-like receptor genome regions in cynomolgus macaque
por: Hu, Qingxiu, et al.
Publicado: (2022)

Ventricular Tachycardia from a Central Line Fracture Fragment Embolus: A Rare Complication of a Commonly Used Procedure—A Case Report and Review of the Relevant Literature
por: Biswas, Saptarshi, et al.
Publicado: (2015)

Myiasis on a Giant Squamous Cell Carcinoma of the Scalp: A Case Report and Review of Relevant Literature
por: Biswas, Saptarshi, et al.
Publicado: (2016)

Furuncular Myiasis of the Scalp
por: Biswas, Saptarshi, et al.
Publicado: (2016)

Identifying Major Histocompatibility Complex Supertypes
por: Guan, Pingping, et al.
Publicado: (2007)

Structure of Human Histocompatibility Leukocyte Antigen (Hla)-Cw4, a Ligand for the Kir2d Natural Killer Cell Inhibitory Receptor
por: Fan, Qing R., et al.
Publicado: (1999)

A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells
por: Colonna, Marco, et al.
Publicado: (1997)

Conditional analysis of the major histocompatibility complex in rheumatoid arthritis
por: Taylor, Kimberly E, et al.
Publicado: (2009)

Expression Profiling of Major Histocompatibility and Natural Killer Complex Genes Reveals Candidates for Controlling Risk of Graft versus Host Disease
por: Novota, Peter, et al.
Publicado: (2011)

CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma
por: Ottaviani, Diego, et al.
Publicado: (2012)

Generation of Lytic Natural Killer 1.1(+), Ly-49(−) Cells from Multipotential Murine Bone Marrow Progenitors in a Stroma-free Culture: Definition of Cytokine Requirements and Developmental Intermediates
por: Williams, Noelle Sevilir, et al.
Publicado: (1997)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Xenograft models for pediatric cancer therapies
por: McNerney, Kevin O, et al.
Publicado: (2021)

Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes
Publicado: (1993)

Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ver1f5p7dc19frh53k9r26q0b4